Zealand Pharma A/s Stock
€42.60
Your prediction
Financial data and news for Zealand
sharewise wants to provide you with the best news and tools for Zealand, so we directly link to the best financial data sources.
Financials
News
Sensus Healthcare Q2 Earnings Call Highlights
Key Points
- Interested in Sensus Healthcare, Inc.? Here are five stocks we like better.
- Second-quarter revenue fell sharply to $2.3 million from $7.3 million a year earlier, primarily because
Merlin, Inc. Common Stock Q2 Earnings Call Highlights
Key Points
- Interested in Merlin, Inc. Common Stock? Here are five stocks we like better.
- Second-quarter revenue rose to approximately $2.2 million, up $1.2 million sequentially, while Merlin
Entain H1 Earnings Call Highlights
Key Points
- Interested in Entain Plc? Here are five stocks we like better.
- Entain reported strong first-half growth: Online net gaming revenue increased 7% in constant currency, group EBITDA
LENZ Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in LENZ Therapeutics, Inc.? Here are five stocks we like better.
- Q2 revenue reached $5.5 million, including more than $1.7 million in VIZZ product revenue and $3.8
JBS Q2 Earnings Call Highlights
Key Points
- Interested in Jbs N.V.? Here are five stocks we like better.
- JBS reported record second-quarter sales of $24 billion, with adjusted EBITDA of $1.43 billion under IFRS and adjusted net
WSP Global Q2 Earnings Call Highlights
Key Points
- Interested in WSP Global Inc.? Here are five stocks we like better.
- WSP delivered a strong second quarter: Net revenue rose about 23% year over year, adjusted EBITDA increased 29% to
Aurora Cannabis Shareholders Approve Board as Fiscal 2026 Results Beat Outlook
Key Points
- Interested in Aurora Cannabis Inc.? Here are five stocks we like better.
- Shareholders approved all proposals, including a five-member board, the election of Aurora’s director
Beauty Health Q2 Earnings Call Highlights
Key Points
- Interested in The Beauty Health Company? Here are five stocks we like better.
- Second-quarter results were mixed: Revenue fell 7.8% year over year to $72.1 million, pressured by
Vir Biotechnology Q2 Earnings Call Highlights
Vir Biotechnology (NASDAQ:VIR) reported second-quarter 2026 results alongside updates on its chronic hepatitis delta and oncology programs
Remitly Global Q2 Earnings Call Highlights
Key Points
- Interested in Remitly Global, Inc.? Here are five stocks we like better.
- Strong second-quarter performance: Revenue rose 20% year over year to $495 million, while adjusted EBITDA
Aurora Cannabis Q1 Earnings Call Highlights
Key Points
- Interested in Aurora Cannabis Inc.? Here are five stocks we like better.
- International medical cannabis drove growth: Revenue rose to C$67.6 million, with international medical
Roblox Q2 Earnings Call Highlights
Key Points
- Interested in Roblox Corporation? Here are five stocks we like better.
- Roblox’s Q2 revenue grew 36% to $1.5 billion, while bookings rose 8% to $1.6 billion, near the low end of
Robert Walters H1 Earnings Call Highlights
Robert Walters (LON:RWA) said its first-half 2026 performance was in line with expectations as the recruitment firm reduced costs, continued cash-management actions and reported improving trends in
HICL Infrastructure Targets 10%+ Returns With Self-Funded Growth Strategy
Key Points
- Interested in HICL Infrastructure PLC? Here are five stocks we like better.
- HICL Infrastructure is targeting 10%+ medium-term total returns by shifting more of its portfolio toward
Merlin, Inc. Common Stock Q1 Earnings Call Highlights
Key Points
- Interested in Merlin, Inc. Common Stock? Here are five stocks we like better.
- Merlin used its first public-company earnings call to spotlight its autonomous flight strategy
SAB Biotherapeutics Q1 Earnings Call Highlights
SAB Biotherapeutics (NASDAQ:SABS) said its lead type 1 diabetes candidate, SAB-142, remains on track in a registrational Phase 2b trial, as the
Why Rocket Lab Stock Just Jumped
Rocket Lab Corporation (NASDAQ: RKLB) jumped 9.5% on Friday. The S&P 500 and the Nasdaq Composite were up 0.6% and 1.2%, respectively.
Shares of the rocket and satellite manufacturer were lifted by
Australia, Brazil, Chile, and New Zealand Object to Trump's New Tariffs, Adding Trade War Uncertainty That Investors Should Watch
President Donald Trump has not stopped using tariffs. In February, the Supreme Court ruled that the president's previous attempt at emergency-powers tariffs was unconstitutional. Now Trump is trying
2 Missions, 3 Launches, and Up to $300 Million for Rocket Lab
Rocket Lab (NASDAQ: RKLB) is on a roll -- not that you could tell from the stock price.
Shares of the tiny, U.S.- and New Zealand-based Space Exploration Technologies lookalike are down 32% so far
Why Rocket Lab Stock Went to the Moon Today
Rocket star Rocket Lab (NASDAQ: RKLB) is making headlines again this morning, after completing yet another satellite launch for Synspective over the weekend. (They also delayed a launch for iQPS,
A Weight-Loss Rival Just Crashed 23%. Why That's Great News for Eli Lilly and Novo Nordisk.
The GLP weight-loss space has become increasingly competitive as new players have entered what many believe is a game-changing new market that’s still in the early innings.
But getting in the game